Pulmonary thrombosis after COVID-19 infection in a hypertensive patient, a case report

Authors

Keywords:

COVID-19, Hypertension, Infection, Respiratory system, Intensive care unit, Virus

Abstract

Introduction: COVID-19 is a disease that decreases lung capacity, even more so if the infection occurs in patients with an underlying heart condition that could influence the respiratory system. Statistically, hypertension is the vascular condition most frequently associated with deaths from the virus.

?

Objective: to describe the clinical course of a hypertensive patient after being infected with COVID-19.

?

Case presentation: the case of a hypertensive patient for 26 years who started with symptoms suggestive of respiratory infection was presented. After being examined and with positive complementary tests, the patient was diagnosed with COVID-19 disease. He was treated in the Intensive Care Unit until he was discharged alive with marked improvement and negative tests for respiratory infection.

?

Conclusions: before a presumed respiratory infection, complementary drugs should be indicated, including the polymerase chain reaction. Once the infection is diagnosed, the patient should receive intensive therapy, monitoring, and treatment of complications.

?

Downloads

Download data is not yet available.

References

Cañete Villafranca R, Noda Albelo AL, Ferreira Moreno V, Brito Pérez K, García Herrera AL. SARS-Cov-2, el virus emergente que causa la pandemia de COVID-19. Rev Med Electrón. 2020 [Citado 27 Dic 2022 ]; 42(3): 1862-1881. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242020000301862&lng=es

Organización Panamericana de la Salud / Organización Mundial de la Salud. Actualización epidemiológica: Alerta epidemiológica brotes recurrentes de Covid-19. 2022. Washington D.C.: OPS/OMS; 2022[Citado 27 Dic 2022]. Disponible en: https://www.paho.org/es/documentos/alerta-epidemiologica-brotes-recurrentes-covid-19-15-junio-2022

Beldarraín Chaple E, Alfonso Sánchez IR, Morales Suárez I, Durán García F. Primer acercamiento histórico epidemiológico a la COVID-19 en Cuba. Academ Cien Cuba. 2020 [Citado 27 Dic 2022]; 10(2): 862. Disponible en: https://www.revistaccuba.sld.cu/index.php/revacc/article/view/862

Jorna Calixto AR, Véliz Martínez PL, Vidal Ledo MJ, Véliz Jorna AL. Gestión de los riesgos sanitarios en el enfrentamiento a la COVID-19 en Cuba. Rev Cubana Salud Pública. 2020 [Citado 29 Dic 2022]; 46(1): e2696. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662020000500008&lng=es

Ministerio de Salud Pública de Cuba. Parte del cierre del 9 de junio a las 12 de la noche. La Habana: Minsap; 2021 [Citado 7 Ene 2023]. Disponible en: https://salud.msp.gob.cu/

Paules CI, Marston HD, Fauci AS. Coronavirus Infections-More Than Just the Common Cold. JAMA. 2020 [Citado 7 Ene 2023]; 323(8):707-8. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2759815

Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020[Citado 7 Ene 2023]; 58(7):1-10. Disponible en: https://doi.org/10.1515/cclm-2020-0198

Villafuerte Delgado D, Ojeda Delgado L, Valladares Valle M, Díaz Yanes NM, Yanes Isray O, Cerda Parra G. Aspectos imagenológicos útiles en el diagnóstico y seguimiento de pacientes con COVID-19. Medisur. 2020 [Citado 11 Ene 2023]; 18(5): 886-898. Disponible en: http://medisur.sld.cu/index.php/medisur/article/view/4715

Sánchez Sánchez NF, Salas Coronado R. Origen, características estructurales, medidas de prevención, diagnóstico y posibles fármacos para prevenir y COVID-19. Medwave. 2020 [Citado 12 Ene 2023]; 20(8): e8037. Disponible en: https://www.medwave.cl/link.cgi/Medwave/Revisiones/RevisionClinica/8037.act

Fragiel M, Canora Lebrato J, Candel FJ, Zapatero Gaviria A, Martínez JM, González del Castillo J. Diagnóstico diferencial de las neumonías en los tiempos de Covid-19. Rev.Esp de Quimio. 2020 [Citado 16 Ene 2023]; 33(5): 387-389. Disponible en: https://seq.es/wp-content/uploads/2020/08/gonzalez03aug2020.pdf&ved=2ahUKEwj1zcK13pDxAhX0QzABHX1qBZ4QFjAGegQIBxAC&usg=AOvVaw3WiHHMjZnyYBsz1n2VafQ5

Ochoa Montes LA, Ferrer Marrero D. Daño cardiovascular en la COVID-19: Una extensión de la enfermedad pulmonar. CorSalud. 2021 [Citado 17 Ene 2023]; 13(1): 68-85. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/download/715/1298&ved=2ahUKEwj-oq605pDxAhVzQTABHftWBzAQFjAAegQICBAC&usg=AOvVaw3yOgya1U9D_c4pOpWquLtV

Pérez Peña J. Estrategia cubana para combatir la COVID-19 con medicamentos nacionales. Rev. Cub Farm. 2020 [Citado 17 Ene 2023]; 53(2): e457. Disponible en: http://www.revfarmacia.sld.cu/index.php/far/article/download/457/303&ved=2ahUKEwjpyqeZ7ZDxAhXzSjABHb3gBscQFjACegQICBAC&usg=AOvVaw023cgDx00yDYGq3ylPTYA-

Llover MN, Jiménez MC. Estado actual de los tratamientos para la COVID-19. FCM. 2021 [Citado 17 Ene 2023]; 28(1):40-56. Disponible en: https://www.fmc.es/es-estado-actual-tratamientos-covid-19-articulo-S1134207220301717

García Céspedes ME, Bell Castillo J, Romero Calzado DE, Ferrales Biset N. La COVID-19 en personas hipertensas. MEDISAN. 2020 [Citado 24 Ene 2023]; 24 (3): 501-514. Disponible en: http://www.medisan.sld.cu/index.php/san/article/view/3107

Downloads

Published

2023-03-09

How to Cite

1.
Izaguirre Campillo YL, Pujol Arias L, Salinas Viamonte HF. Pulmonary thrombosis after COVID-19 infection in a hypertensive patient, a case report. Columna méd. [Internet]. 2023 Mar. 9 [cited 2025 Jan. 19];2(1):e74. Available from: https://revcolumnamedica.sld.cu/index.php/columnamedica/article/view/74

Issue

Vol. 2 No. 1 (2023): Enero-Abril

Section

Case presentations

License

Copyright (c) 2023 Yander Luis Izaguirre Campillo, Lizandra Pujol Arias, Hanna Flabia Salinas Viamonte

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

You are free of:

  1. Share copy and redistribute the material in any medium or format
  2. Adapt Remix, transform and build from material
  3. The licensor cannot revoke these freedoms as long as you follow the terms of the license

Under the following terms:

  1. Attribution - Oh, it's a good thing. You must give adequate credit , provide a link to the license, e indicate whether changes have been made . You can do it in any reasonable way, but not in such a way as to suggest that you or your use have the support of the licensor.
  2. Non-Commercial - Oh, it's a . You can't make use of the material with commercial purposes .
  3. No additional restrictions You can't apply legal terms or technological measures that legally restrict others from making any use permitted by the license.

Most read articles by the same author(s)